High CXCR2 expression has been associated with poor prognosis in various cancers, including acute myeloid leukemia, breast cancer, and ovarian cancer, due to its role in promoting tumor cell proliferation and metastasis [36]. Here, CXCR2 is linked to breast carcinoma.